Sean joined Alvotech as Chief Technical Officer in May 2020. Sean joins Alvotech with a significant experience in biologics manufacturing (both mAb and AAV platforms), pharmaceutical (chemical) operations, technical operations strategy, QA compliance and research chemistry. Prior to joining Alvotech Sean served as Site Head and Vice President of Manufacturing Operations at AveXis (a Novartis company) based in Illinois, USA.
Sean played a leading role in the transformational change of AveXis’ core facility producing AAV9-based gene therapies to become a commercial supplier of live-saving medicines for patients with rare diseases. Prior to AveXis, Sean worked at Novartis headquarters in Basel, Switzerland, where he was the site head responsible for the manufacture of clinical biopharmaceutical drug substance (innovators and biosimilars) and the accelerated launch of three commercial products. After joining Novartis in 2009, Sean held roles of increasing responsibility in Technical Operations, including an assignment as strategic assistant to Novartis’ Global Head of Technical Operations, to develop, implement and monitor the company’s long-term technical operations strategy across more than 50 sites worldwide.
Sean holds a BSc with first class honours in chemistry, a PhD in organic chemistry from Loughborough University, UK, and a diploma in industrial studies.